Horizon Therapeutics

Amgen plans to lay off 350 former Horizon employees after $28B buyout
Amgen plans to lay off 350 former Horizon employees after $28B buyout
Fierce Pharma
Amgen
Horizon Therapeutics
layoffs
M&A
Flag link:
Amgen Completes $27.8B Horizon Acquisition Following FTC Challenge
Amgen Completes $27.8B Horizon Acquisition Following FTC Challenge
BioSpace
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
BioSpace
Amgen
Horizon Therapeutics
FTC
antitrust
M&A
Flag link:
FTC allows Amgen’s $27.8B purchase of Horizon to proceed
FTC allows Amgen’s $27.8B purchase of Horizon to proceed
Medical Marketing and Media
FTC
Amgen
Horizon Therapeutics
M&A
Flag link:
FTC Temporarily Withdraws Challenge to $27.8B Amgen-Horizon Deal
FTC Temporarily Withdraws Challenge to $27.8B Amgen-Horizon Deal
BioSpace
FTC
Amgen
Horizon Therapeutics
M&A
Flag link:
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
Fierce Pharma
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
Amgen’s lupus bets continue to flounder, even those on the Horizon
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Horizon Therapeutics
Amgen
lupus
daxdilimab
clinical trials
Flag link:
Key Horizon drug Tepezza has hearing loss warning added to labeling
Key Horizon drug Tepezza has hearing loss warning added to labeling
Seeking Alpha
Horizon Therapeutics
Tepezza
hearing loss
thyroid eye disease
Flag link:
FTC, Amgen Break Off Settlement Talks Over Horizon Deal
FTC, Amgen Break Off Settlement Talks Over Horizon Deal
BioSpace
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
Viridian Poised to Challenge Horizon in Thyroid Eye Disease
Viridian Poised to Challenge Horizon in Thyroid Eye Disease
BioSpace
Viridian Therapeutics
VRDN-001
thyroid eye disease
Horizon Therapeutics
Flag link:
Biopharma buyouts bounce back
Biopharma buyouts bounce back
EP Vantage
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Flag link:
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
BioSpace
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Flag link:
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Horizon Therapeutics
M&A
Amgen
FTC
Flag link:
Few signs of gout pipeline flaring up
Few signs of gout pipeline flaring up
EP Vantage
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Flag link:
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:

Pages